F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

NYT > U.S. > PoliticsModerna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.​Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. ​Read More